Simcere Pharmaceutical Files Next-Day Return With HKEX Disclosing Share BuybackPUBT·Nov 18, 2026 at 10:02 AM02096-0.76%
Simcere Pharmaceutical Files HKEX Next-Day Return Disclosing Share BuybackPUBT·Nov 17, 2026 at 09:31 AM02096-0.76%
Simcere’s Sanbexin Sublingual Tablets Added to China’s 2026 Reimbursement ListTip Ranks·Nov 15, 2026 at 11:13 PM02096-0.76%
Weekly Recap | SIMCERE PHARMA -5.54%, two pipeline winsWeekly Review·Nov 14, 2026 at 05:16 AM02096-0.76%
Simcere Pharmaceutical Files Next-Day Return to HKEX Disclosing Share Buyback for CancellationPUBT·Nov 11, 2026 at 10:59 AM02096-0.76%
China Accepts Simcere’s Zemprocitinib Application for Rheumatoid Arthritis ReviewPUBT·Nov 6, 2026 at 04:11 AM02096-0.76%
Simcere Pharma climbs 5% on zeupocitinib dermatology dealMarket Movers·Nov 4, 2026 at 06:16 AM02096-0.76%
Simcere Pharmaceutical Files HKEX Return Disclosing Share Buyback for CancellationPUBT·Nov 3, 2026 at 11:08 AM02096-0.76%
Simcere Pharmaceutical Group Limited (2096) Gets a Buy from UBSbusinessinsider·Oct 31, 2026 at 06:43 AM02096-0.76%